IQVIA Asia Pacific

Last week, our Taiwan office hosted an engaging Online Coffee Chat, where employees discussed their daily work, challenges, and career growth at IQVIA. This was our second episode, following the excellent feedback from the April session. During the session, our Senior CRA, Lai Stella, shared her remarkable journey from Site Activation Specialist to CRA, and how she balances her professional life with motherhood. Check out the highlights from the event and explore career opportunities at IQVIA today: https://bit.ly/4e4eSXM #WeAreIQVIA #CareerGrowth

Webinar Alert! Join us on Monday, September 16, 2024, at 7:30 am EST (5:00 pm IST) for an insightful webinar on Regulatory Strategies for Biosimilars and Generics for Global Success where industry experts will delve into key strategies for the global development and market expansion of biosimilars and generics. Register here https://lnkd.in/gQyjjrn6 now and be part of the conversation that shapes the future of biosimilars and generics! #RegulatoryStrategies #IQVIAWebinar Keith McDonald Rama Mohan Rao Chikkam Ankit Tyagi Amar Tandon PMP® Raina Singh Paplikar

Don’t miss out on our upcoming webinar happening in 2 weeks! Join us as we delve into #FDAinitiatives like #ProjectOptimus and Project FrontRunner, and their significant impact on JAPAC biopharma. Gain insights into the evolving regulatory landscape, early-phase oncology, and strategies for global expansion. Stay ahead in oncology innovation! Register now and secure your spot! https://bit.ly/3ACAj3r #ClinicalDevelopment #IQVIAwebinar

IQVIA Institute’s Pre-ESMO 2024 Symposium will be held on 13 Sept, both in person and virtually. This event is open to the public at no cost. Join us to explore how we can strengthen Europe as a global center for oncology trials: https://lnkd.in/g6VtUsbV

#Obesity is a major global health crisis impacting every corner of the world, with an estimated 1.9 billion obese people by 2035. We are at an inflection point as new novel obesity treatments have created meaningful outcomes. Innovators are venturing into pipelines that do not focus and impact only on obesity, but also the co-morbidities associated with it. Read more on Markus Gores and Sarah Rickwood’s breakdown of the future obesity market: https://bit.ly/46YoyAF #obesitytrial #glp1 #metabolichealth

We are thrilled to share the resounding success of the recent IQVIA Consumer Health Indonesia Forum 2024 in Jakarta. 🌟 Join us as we revisit discussions on 'Embracing self-care' that set a new standard in Jakarta. The event focused on accessibility and inclusivity in self-care products, emphasizing cultural diversity and ethical practices. Explore the future of personalized healthcare with us. To Learn more about how IQVIA can help you stay ahead in the ever-evolving consumer health industry. Click here - https://bit.ly/3XdDY0G Jowel Tacata @Anand Srinivasan Airene Valencia Mairin Reid Ashari Fitriyansyah (Ari) Raymond R. Tjandrawinata, Ph.D. Erwin Widjaja Seisar Ariestiadi Jazreel Seow Yogesh Pardeshi

Join our 'Global Trends in R&D 2024' webinar as our thought leaders share their insights and analysis on the latest trends, emerging drug launches, R&D funding, and more. What can you expect from this session? • Discover shifts in clinical development from COVID-19 to new oncology and rare disease therapies. • Learn about innovative, technology-driven enablers boosting clinical productivity. • Get insights on the reset of R&D funding levels post-2020.   Register now and don’t miss out on Asia’s growth in driving R&D trends! https://bit.ly/3XdRiSz #RandD #biopharma #clinicaltrials

Meet Shyamal Talgaonkar and Sangita Singh, Associate Directors from the Clinical FSP and Global Site Activation teams! In this video, Shyamal and Sangita delve into their roles and highlight how #collaboration between their teams plays a key part in advancing healthcare. Their teamwork is essential in ensuring that clinical trials start on the right foot, aligning with both client needs and regulatory standards. Shyamal and Sangita take pride in making a difference in healthcare, dedicating themselves to improving the lives of patients around the world. Watch the short video to learn more about their work. Start your career with IQVIA: https://bit.ly/4fTa0Gz #WeAreIQVIA #MeetTheIQVIAN

🔔 Happening today! Have you registered? Register and attend the '𝗡𝗮𝘃𝗶𝗴𝗮𝘁𝗶𝗻𝗴 𝘁𝗵𝗲 𝗘𝘃𝗼𝗹𝘃𝗶𝗻𝗴 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲: 𝗧𝗵𝗲 𝗙𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗛𝗖𝗣 𝗘𝗻𝗴𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗜𝗺𝗽𝗮𝗰𝘁' webinar to uncover up-to-date insights into the HCP engagement landscape and sharpen your go-to-market strategies. Click here to register - https://bit.ly/3SZbkxw Pradipto Goswamee - Ben Gallarda, PhD - Jonathan Macdonald - Jazreel Seow #HCPengagement #Digitalhealth #healthcare

A new report developed by IQVIA ANZ’s consulting team has been published by the Australian Department of Health and Aged Care, following the Residents’ Experience Survey (RES), an extensive national survey capturing the voices of 35,000 aged care residents across Australia. The latest RES was conducted by a consortium led by IQVIA, offering crucial insights into the quality of services received by older Australians in residential aged care. By leveraging advanced analytical techniques such as natural language processing and machine learning, the IQVIA team identified key areas for enhancing the resident experience and collaborated closely with the Department of Health and Aged Care to produce this report. Key findings include: ✔️ Positive changes in the residential aged care experience from 2022 to 2023 ✔️ High satisfaction with safety, respect and kindness in aged care homes ✔️ Significant improvement in residents’ autonomy ✔️ Food quality identified as the main area for improvement ✔️ Lower satisfaction among residents with high care needs ✔️ Larger aged care homes received less positive responses compared to smaller homes Read on to learn more about the RES findings: https://bit.ly/3WXfffA Or download the fact sheet here: https://bit.ly/3yQzJyD Quentin Bracquart - Michael D. - Brandon Wright, Ph.D - Angel Das #AgedCareAustralia #ConsumerExperience